What specific rating change did Zacks Research make for Chemours, and what triggered it?

Zacks Research downgraded Chemours (NYSE: CC) from a 'strong-buy' to a 'strong sell' rating. This downgrade followed Chemours' recent quarterly earnings report, in which the company missed analyst estimates for both earnings per share (EPS) and revenue.

How do other analysts currently view Chemours, and what notable insider activity is mentioned?

While Zacks Research issued a 'strong sell', other analysts maintain a 'Hold' rating for Chemours, with a consensus price target of $21.00. Additionally, the company's CFO, Shane Hostetter, recently purchased additional shares—an action noted as insider buying in the news body.

Chemours Downgraded to 'Strong Sell' by Zacks Research

Aug 13, 2026

Zacks Research downgraded Chemours to 'Strong Sell' following missed quarterly earnings estimates for EPS and revenue. Analyst consensus remains Hold with a $21 price target despite the recent downgrade.

MarketBeat

2026-04-17

Chemours' Fayetteville Works Earns Gold-Level WHC Conservation Certification for Environmental Excellence

2026-04-18

Chemours Company Receives Average 'Hold' Recommendation from Brokerages

2026-04-21

Chemours' West Virginia Forest Partnership Delivers Measurable Climate and Community Impact After Five Years

2026-04-21

Chemours to Release Q1 2026 Results May 5, Host Webcast

2026-04-22

Activists Demand No-Mining Pledge Near Okefenokee Swamp from Chemours